Literature DB >> 12770674

Identification of MeCP2 mutations in a series of females with autistic disorder.

Regina M Carney1, Chantelle M Wolpert, Sarah A Ravan, Mona Shahbazian, Allison Ashley-Koch, Michael L Cuccaro, Jeffery M Vance, Margaret A Pericak-Vance.   

Abstract

Rett disorder and autistic disorder are both pervasive developmental disorders. Recent studies indicate that at least 80% of Rett Disorder cases are caused by mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. Since there is some phenotypic overlap between autistic disorder and Rett disorder, we analyzed 69 females clinically diagnosed with autistic disorder for the presence of mutations in the MeCP2 gene. Two autistic disorder females were found to have de novo mutations in the MeCP2 gene. These data provide additional evidence of variable expression in the Rett disorder phenotype and suggest MeCP2 testing may be warranted for females presenting with autistic disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770674     DOI: 10.1016/s0887-8994(02)00624-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  81 in total

1.  A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing.

Authors:  Steven W Long; Jenny Y Y Ooi; Peter M Yau; Peter L Jones
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.

Authors:  Liron Abuhatzira; Alon Shamir; Dustin E Schones; Alejandro A Schäffer; Michael Bustin
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

3.  Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.

Authors:  Paolo Moretti; Jonathan M Levenson; Fortunato Battaglia; Richard Atkinson; Ryan Teague; Barbara Antalffy; Dawna Armstrong; Ottavio Arancio; J David Sweatt; Huda Y Zoghbi
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 4.  Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Authors:  Lisa M Monteggia; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

5.  Brief report: MECP2 mutations in people without Rett syndrome.

Authors:  Bernhard Suter; Diane Treadwell-Deering; Huda Y Zoghbi; Daniel G Glaze; Jeffrey L Neul
Journal:  J Autism Dev Disord       Date:  2014-03

Review 6.  Evolving role of MeCP2 in Rett syndrome and autism.

Authors:  Janine M LaSalle; Dag H Yasui
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

7.  MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.

Authors:  Hsiao-Tuan Chao; Huda Y Zoghbi; Christian Rosenmund
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

Review 8.  The genetics of autism: key issues, recent findings, and clinical implications.

Authors:  Paul El-Fishawy; Matthew W State
Journal:  Psychiatr Clin North Am       Date:  2010-03

9.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

Review 10.  Autism-lessons from the X chromosome.

Authors:  Elysa J Marco; David H Skuse
Journal:  Soc Cogn Affect Neurosci       Date:  2006-12       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.